Asset Management One Co., Ltd. Novo Cure LTD Transaction History

Asset Management One Co., Ltd.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$16.15 - $42.35 $596,112 - $1.56 Million	-36,911 Reduced 65.64%	19,325 $312,000
Q2 2023 Jul 31, 2023	BUY	$40.29 - $82.51 $1,692 - $3,465	42 Added 0.07%	56,236 $2.33 Million
Q1 2023 Apr 25, 2023	BUY	$56.44 - $118.81 $133,029 - $280,035	2,357 Added 4.38%	56,194 $3.38 Million
Q4 2022 Feb 06, 2023	SELL	$63.98 - $85.37 $226,809 - $302,636	-3,545 Reduced 6.18%	53,837 $3.95 Million
Q3 2022 Nov 04, 2022	BUY	$67.99 - $89.57 $315,881 - $416,142	4,646 Added 8.81%	57,382 $4.36 Million
Q2 2022 Jul 29, 2022	SELL	$56.6 - $89.9 $11,320 - $17,980	-200 Reduced 0.38%	52,736 $3.67 Million
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $25,202 - $35,413	-419 Reduced 0.79%	52,936 $4.39 Million
Q4 2021 Feb 09, 2022	SELL	$75.08 - $121.99 $106,688 - $173,347	-1,421 Reduced 2.59%	53,355 $4.18 Million
Q3 2021 Nov 02, 2021	BUY	$116.17 - $194.55 $185,639 - $310,890	1,598 Added 3.01%	54,776 $6.36 Million
Q2 2021 Aug 03, 2021	BUY	$130.4 - $225.58 $135,485 - $234,377	1,039 Added 1.99%	53,178 $11.8 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $143,222 - $219,456	-1,154 Reduced 2.17%	52,139 $6.89 Million
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $4.53 Million - $7.04 Million	40,410 Added 313.67%	53,293 $9.01 Million
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $535,585 - $898,901	9,388 Added 268.61%	12,883 $868,000
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $238,708 - $327,831	3,495 New	3,495 $295,000

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asset Management One Co., Ltd. with notifications on news.